DuFresne, Duffy

Summary of Experience:

Mr. DuFresne has 35 years of experience in the biopharmaceutical and medical device industries. He currently is CEO of Medrock, a Portland-based medical device firm, CBO of TomegaVax, a vaccine firm spun out of OHSU, as well as a partner in Alignment Ventures. Previously he served as CEO of Ischemix, Pacgen, Zelos Therapeutics, ConjuChem, Inc and Anika Therapeutics. Duffy has raised more than $200 million in equity for the companies he has run and negotiated a large number of partnering/licensing agreements. His medical device and pharmaceutical industry experience includes general management at Baxter Laboratories and Boots Pharmaceuticals.

Mr. DuFresne serves on several corporate boards as well as the board for the Portland chapter of the Association for Corporate Growth. He also is a strategic advisory group member at OHSU. He earned an MBA from the Harvard Business School.

Mentoring Services Provided:

Mr. DuFresne can provide early stage life science firms with advice related to raising finance, developing business plans, negotiating partnering agreements, in-licensing intellectual property, structuring business presentations and general strategy/planning.